GCG and Hypoglycemia: The effectiveness of somatostatin analogues in preventing hypoglycemic episodes is estimated at 40–60% of cases, but it can inhibit the release of counterregulatory hormones, such as glucagon, which can even worsen hypoglycemia in some patients [22].